IT1407612B1 - OPHTHALMIC COMPOSITIONS FOR NUTRITION, MAINTAINING THE INTEGRITY OF THE EPITHELIUM OF THE EYE AND THE PROTECTION OF THEMSELVES FROM OXIDATION. - Google Patents

OPHTHALMIC COMPOSITIONS FOR NUTRITION, MAINTAINING THE INTEGRITY OF THE EPITHELIUM OF THE EYE AND THE PROTECTION OF THEMSELVES FROM OXIDATION.

Info

Publication number
IT1407612B1
IT1407612B1 ITGE2011A000004A ITGE20110004A IT1407612B1 IT 1407612 B1 IT1407612 B1 IT 1407612B1 IT GE2011A000004 A ITGE2011A000004 A IT GE2011A000004A IT GE20110004 A ITGE20110004 A IT GE20110004A IT 1407612 B1 IT1407612 B1 IT 1407612B1
Authority
IT
Italy
Prior art keywords
epithelium
nutrition
integrity
themselves
eye
Prior art date
Application number
ITGE2011A000004A
Other languages
Italian (it)
Inventor
Aurelio Iurilli
Original Assignee
Baif Internat Products New York S N C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baif Internat Products New York S N C filed Critical Baif Internat Products New York S N C
Priority to ITGE2011A000004A priority Critical patent/IT1407612B1/en
Publication of ITGE20110004A1 publication Critical patent/ITGE20110004A1/en
Application granted granted Critical
Publication of IT1407612B1 publication Critical patent/IT1407612B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITGE2011A000004A 2011-01-13 2011-01-13 OPHTHALMIC COMPOSITIONS FOR NUTRITION, MAINTAINING THE INTEGRITY OF THE EPITHELIUM OF THE EYE AND THE PROTECTION OF THEMSELVES FROM OXIDATION. IT1407612B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITGE2011A000004A IT1407612B1 (en) 2011-01-13 2011-01-13 OPHTHALMIC COMPOSITIONS FOR NUTRITION, MAINTAINING THE INTEGRITY OF THE EPITHELIUM OF THE EYE AND THE PROTECTION OF THEMSELVES FROM OXIDATION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITGE2011A000004A IT1407612B1 (en) 2011-01-13 2011-01-13 OPHTHALMIC COMPOSITIONS FOR NUTRITION, MAINTAINING THE INTEGRITY OF THE EPITHELIUM OF THE EYE AND THE PROTECTION OF THEMSELVES FROM OXIDATION.

Publications (2)

Publication Number Publication Date
ITGE20110004A1 ITGE20110004A1 (en) 2012-07-14
IT1407612B1 true IT1407612B1 (en) 2014-04-30

Family

ID=43975330

Family Applications (1)

Application Number Title Priority Date Filing Date
ITGE2011A000004A IT1407612B1 (en) 2011-01-13 2011-01-13 OPHTHALMIC COMPOSITIONS FOR NUTRITION, MAINTAINING THE INTEGRITY OF THE EPITHELIUM OF THE EYE AND THE PROTECTION OF THEMSELVES FROM OXIDATION.

Country Status (1)

Country Link
IT (1) IT1407612B1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2939082B2 (en) * 1993-02-23 1999-08-25 ライオン株式会社 Stable vitamin A palmitate and vitamin E solubilized eye drops
US6291519B1 (en) * 1998-10-14 2001-09-18 Novartis Ag Method of preventing damage to eye tissue
AU2001286578A1 (en) * 2000-08-24 2002-03-04 Tim Ioannides Topical antioxidant having vitamin c and method of combination with topical agent by user
US20100069335A1 (en) * 2005-07-15 2010-03-18 Rajiv Bhushan Prevention and Treatment of Ophthalmic Complications of Diabetes
CA2615360A1 (en) * 2005-07-15 2007-01-25 Chakshu Research Inc. Formulation and method for administration of ophthalmologically active agents

Also Published As

Publication number Publication date
ITGE20110004A1 (en) 2012-07-14

Similar Documents

Publication Publication Date Title
PL2768937T3 (en) Formulations, their use as or for the manufacture of dishwashing agents and their manufacture
MY171920A (en) Prevention and treatment of ocular conditions
CO7000769A2 (en) Compositions and methods for the treatment of presbyopia, mild farsightedness, and irregular astigmatism
HK1214168A1 (en) Compositions, methods and uses for the treatment of diabetes and related conditions by controlling blood glucose level
WO2012177757A3 (en) Personal care compositions comprising shaped abrasive particles
TR201905683T4 (en) Ophthalmic formulation and method for erosive presbyopia.
IT1404931B1 (en) OPHTHALMIC COMPOSITIONS FOR THE ADMINISTRATION OF LIPO-SOLUBLE ACTIVE PRINCIPLES.
IL227412A (en) Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2012106393A3 (en) Withanolide isolated from physalis longifolia and analogs and methods of use thereof
FR2955253B1 (en) COSMETIC METHOD FOR MODIFYING THE APPEARANCE OF THE CONTOUR OF THE EYE.
WO2013003669A3 (en) Compositions, methods of use, and methods of treatment
CL2014003123A1 (en) 5-amino [1,4], thiazines as bace1 inhibitors; use of the compound against Alzheimer's disease.
IT1398378B1 (en) CYTICOLINE FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION.
EP2910247A4 (en) Compositions for preventing or treating allergic skin disorders, containing gpcr19 agents as active ingredients
BR112012025490A2 (en) '' method for the production of 1,5 oebtanodiamine ''
WO2012154879A3 (en) Autophagy inhibitors
IT1401289B1 (en) COMPOUNDS WITH ANTIOXIDANT ACTIVITY TOWARDS THE FREE RADICALS, AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT CONTAIN THEM
WO2014105777A8 (en) Cobicostat dichlohydrate salt
WO2013155465A8 (en) Substituted xanthine derivatives
WO2013038195A3 (en) Pharmaceutical nanoparticle compositions
WO2013033602A3 (en) Fatty acid amides, compositions and methods of use
WO2012061165A3 (en) Methods and compositions for improving admet properties
IT1407612B1 (en) OPHTHALMIC COMPOSITIONS FOR NUTRITION, MAINTAINING THE INTEGRITY OF THE EPITHELIUM OF THE EYE AND THE PROTECTION OF THEMSELVES FROM OXIDATION.
WO2014005942A3 (en) Essential oil of sweet marjoram, composition comprising it, cosmetic treatment method and use